Fairhaven Health Revenue and Competitors

Bellingham, WA USA

Location

N/A

Total Funding

Health

Industry

Estimated Revenue & Valuation

  • Fairhaven Health's estimated annual revenue is currently $7.8M per year.(i)
  • Fairhaven Health's estimated revenue per employee is $216,000

Employee Data

  • Fairhaven Health has 36 Employees.(i)
  • Fairhaven Health grew their employee count by -5% last year.

Fairhaven Health's People

NameTitleEmail/Phone
1
VP SalesReveal Email/Phone
2
VP Operations & Project ManagementReveal Email/Phone
3
Chief Financial OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.5M30-12%N/AN/A
#2
$12.9M530%N/AN/A
#3
$279.3M7397%N/AN/A
#4
$1.9M129%N/AN/A
#5
$5.3M284%N/AN/A
#6
$358.7M9496%N/AN/A
#7
$8.4M398%N/AN/A
#8
$14.1M5814%N/AN/A
#9
$85.2M2878%N/AN/A
#10
$17M709%N/AN/A
Add Company

What Is Fairhaven Health?

Fairhaven Health is a specialty supplier of doctor-designed products to support fertility enhancement, pregnancy, breastfeeding and overall women’s health. We offer the broadest range of products to support fertility treatment protocols as well as to help couples conceive naturally. Once pregnancy is achieved, we provide a variety of prenatal supplements and our award-winning Milkies nursing products to help new moms meet their breastfeeding goals. Most recently, we have launched our Vaginal Care & Comfort line of of paraben-free, isotonic gels to support vaginal health through all life stages. Fairhaven Health is an ISO-13485 certified company with all products manufactured in N. America in GMP-certified facilities from domestic and imported ingredients – quality you can count on. Founded in 2003, Fairhaven Health is located in Bellingham, Washington.

keywords:N/A

N/A

Total Funding

36

Number of Employees

$7.8M

Revenue (est)

-5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$10.1M36-3%N/A
#2
$5M369%N/A
#3
$4.4M373%N/A
#4
$7.5M379%N/A
#5
$8.1M386%N/A